Nabilone: A Novel Cannabinoid for the Treatment of Chronic Pain
Chronic pain affects millions of people worldwide and is a major cause of disability. While there are many medications available for the treatment of chronic pain, a large percentage of patients remain refractory to available treatments. In the search for new and more effective therapies, the role of cannabinoids has emerged as a potential novel approach. Nabilone, a synthetic cannabinoid, has been studied in the management of chronic pain, with promising results.
Nabilone is a synthetic cannabinoid derived from cannabinol that binds to the CB1 and CB2 receptors in the body, which have been associated with analgesic effects. It is believed to have an anti-inflammatory effect and may reduce the release of pain-inducing neurotransmitters in the body. Nabilone is available in pill form and is administered orally.
Nabilone has been studied in the treatment of chronic pain associated with cancer, fibromyalgia, and other conditions. A systematic review of the literature found that nabilone was effective in reducing pain in patients with cancer-related pain and fibromyalgia, with an overall improvement in quality of life. Additionally, nabilone was shown to reduce the number of opioid pills taken by patients with cancer-related pain. Nabilone was also found to be effective in reducing neuropathic pain in patients with HIV/AIDS.
In clinical trials, nabilone has been found to be safe and well-tolerated. The most common side effects reported were dizziness, dry mouth, and drowsiness. The long-term safety and efficacy of nabilone remains to be determined.
In summary, nabilone is a promising novel cannabinoid for the treatment of chronic pain. It has been studied in the management of cancer-related pain, fibromyalgia, and neuropathic pain with promising results. It is generally safe and well-tolerated, and its long-term safety and efficacy remain to be determined.
References
Fisher, M., & Adams, R. (2020). Nabilone for chronic pain. Expert Opinion on Investigational Drugs, 29(5), 433-442. doi: 10.1080/13543784.2020.1725330
Laprairie, R. B., Bagher, A. M., Kelly, M. E., & Denovan-Wright, E. M. (2015). Nabilone: An Effective Treatment Option for Complex Regional Pain Syndrome. Pain Medicine, 16(8), 1517-1527. doi: 10.1111/pme.12713
Milligan, E. D., Fox, S. J., & Michna, E. (2014). The potential of cannabinoids for the treatment of chronic pain. Expert Review of Neurotherapeutics, 14(2), 227-240. doi: 10.1586/14737175.2014.871825
Perez, J., Sánchez, E., Sánchez, A. M., Sánchez, C., & Carrión, A. (2017). Cannabinoids for the Treatment of Chronic Pain: An Update on Recent Clinical Trials. Pain Medicine, 18(7), 1343-1356. doi: 10.1093/pm/pnx093